You are here

vericiguat

Clarivate Drugs to Watch Report Highlights Four Likely Blockbusters Among Drugs Launching in 2021

PR Newswire

Tue, 03/9/21 - 10:45 am

Can Merck and Bayer's newly approved Verquvo stand out in an ever-more-competitive heart failure field?

Fierce Pharma

Wed, 01/20/21 - 10:43 am

chronic heart failure

Merck and Bayer unveil the data behind their CV ‘success,’ underwhelming the industry

Endpoints

Mon, 03/30/20 - 10:32 am

clinical trials

ACC: Bayer and Merck’s vericiguat leads off virtual meeting with positive phase 3 heart failure data

Fierce Biotech

Sat, 03/28/20 - 11:25 pm

clinical trials

Upcoming events – Bayer and Merck look to vericiguat, and Akero bets on Nash

EP Vantage

Sat, 01/18/20 - 07:34 pm

Akero Therapeutics

clinical trials

Merck and Bayer's heart drug meets main goal of late-stage study

Yahoo/Reuters

Mon, 11/18/19 - 10:00 am